Pharma Firms Urged To Get Going On EU Lay Summaries
Encapsulating Clinical Trial Results For Patients Is Not Easy
The upcoming EU requirement for summarizing clinical trial results in plain language is a real opportunity for companies to engage with the public. But if companies don’t provide clear and concise information, it may be reduced to a box-ticking exercise.
